Correcting tau isoform ratios with a long-acting antisense oligonucleotide alleviates 4R-tauopathy phenotypes

Key Points

The research aims to investigate the effects of correcting tau isoform ratios using an antisense oligonucleotide in 4R-tauopathies.
Utilized long-acting antisense oligonucleotides for tau isoform correction
Assessed treatment effects on 4R-tauopathy phenotypes
Showed significant reduction in tauopathy symptoms
Achieved favorable gene expression profiles with long-acting treatment

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Demonstrates improved outcomes in 4R-tauopathy through tau isoform correction, suggesting an effective treatment pathway.

expression, thus offering a safe and long-acting treatment for 4R-tau-associated tauopathies.

No takes yet. Share an insight, caveat, or question.

Iwata-Endo et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share